Cerluten
Also known as: Brain peptide bioregulator · Cerluten AA
A brain-derived peptide bioregulator studied in Russian research for CNS and cognitive-related markers.
Cerluten at a glance
| Name | Cerluten |
|---|---|
| Also known as | Brain peptide bioregulator, Cerluten AA |
| Category | Cognitive & neuroprotective |
| Type | Peptide |
| Sequence | Tissue-specific peptide fraction |
| Typical dose | Commonly cited around 1-3 mg per short course |
| Frequency | Short cyclical courses in the discussed protocols |
| Route | Subcutaneous or intramuscular injection (research); oral capsule forms also marketed |
| Half-life | Not well established. |
Overview
Cerluten is described in the bioregulator literature as a peptide complex obtained from brain (central nervous system) tissue. It is discussed mainly in the context of neuroprotection, recovery of nervous-tissue function, and cognitive markers in aging. As with the other bioregulators, the supporting studies come almost entirely from the originating Russian research program, are typically small and dated, and have not been broadly validated in independent Western trials.
How it’s thought to work
- Proposed to act as a CNS-specific peptide bioregulator influencing gene expression in neural tissue.
- Discussed in relation to neuronal maintenance and repair processes.
- Mechanistic claims rest largely on in-house animal and cell work and are not well established elsewhere.
Researched uses
- Neuroprotection interest in aging models
- Cognitive and nervous-system recovery discussions
- Cited alongside other 'brain' peptides in longevity contexts
Commonly cited protocol
| Typical dose | Commonly cited around 1-3 mg per short course |
|---|---|
| Frequency | Short cyclical courses in the discussed protocols |
| Route | Subcutaneous or intramuscular injection (research); oral capsule forms also marketed |
| Notes | Often described as used in repeated cycles in the source literature. |
Reconstitution
Commonly a 5-10 mg vial; reconstitute with bacteriostatic water and use the calculator for units.
Cerluten dosage calculator
The calculator below is pre-filled with Cerluten’s commonly cited vial size and dose. Adjust the vial amount, bacteriostatic water, or dose to match your own vial — it will show the exact insulin-syringe units to draw, the concentration, and how many doses the vial holds.
Add 2 mL of bacteriostatic water to your 10 mg vial. That gives you about 5 doses of 2 mg. For each dose, draw 40 units into a 100-unit insulin syringe.
See the full Cerluten dosing chart (units for every dose & water amount), or open the full peptide calculator →
Cautions
- Not FDA-approved; a research compound rather than an approved neurological treatment.
- Human evidence is limited, older, and largely non-Western, and has not been widely replicated.
- Research-grade or extract material varies in purity and actual peptide content by source.
- Neurological symptoms warrant evaluation by a qualified clinician, not self-directed peptide use.
Cerluten FAQ
What is Cerluten?
A brain-derived peptide bioregulator studied in Russian research for CNS and cognitive-related markers.
How does Cerluten work?
Proposed to act as a CNS-specific peptide bioregulator influencing gene expression in neural tissue. Discussed in relation to neuronal maintenance and repair processes. Mechanistic claims rest largely on in-house animal and cell work and are not well established elsewhere.
What is Cerluten used for?
Neuroprotection interest in aging models; Cognitive and nervous-system recovery discussions; Cited alongside other 'brain' peptides in longevity contexts.
What is a typical Cerluten dose?
Commonly cited around 1-3 mg per short course, Short cyclical courses in the discussed protocols, Subcutaneous or intramuscular injection (research); oral capsule forms also marketed. This is a commonly cited figure for context only, not medical advice.
How do you reconstitute Cerluten?
Commonly a 5-10 mg vial; reconstitute with bacteriostatic water and use the calculator for units.
What is the half-life of Cerluten?
Not well established.